Apimeds Pharmaceuticals US, Inc. (APUS) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NYSE MKT. Price $1.77 (+5.99%), Market cap $0.00B, 52-week low–high $0.11 ~ $1.91.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Financial statements, price targets, institutional (13F) holdings and related news for Apimeds Pharmaceuticals US, Inc. are updated in real time on BlackAll Trade.
Apimeds Pharmaceuticals US, Inc. trades at $1.77 (+5.99%). Real-time quotes and charts are available on BlackAll Trade.
Apimeds Pharmaceuticals US, Inc. has a market cap of about $0.00B.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals